Renal Cell Carcinoma

PASADENA, Calif., July 17, 2026 Xencor, Inc. announced that Phase 1 clinical results for XmAb819, its investigational ENPP3 ×...

SAN DIEGO, July 14, 2026 Kura Oncology announced that updated long-term follow-up data from the ongoing FIT-001 Phase 1a...

SAN DIEGO and PARIS, April 17, 2026 Kura Oncology, Inc. reported encouraging clinical data from its ongoing FIT-001 trial,...

NUTLEY, N.J., Oct. 2, 2025 — Eisai Inc. announced today the presentation of its expansive oncology portfolio at the...